Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01274507 · ClinicalTrials.gov registry record · Early Phase 1
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Early Phase 1 study, sponsored by Janssen Research & Development.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 328
- Enrollment target
NCT01274507 is a Early Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 328 participants.
The verdict
NCT01274507, a Early Phase 1 study, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 328 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
Interventions
- OTHER Medical tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01274507
The ClinicalTrials.gov registry entry for NCT01274507 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical tests is the first listed.
NCT01274507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01274507 about?
NCT01274507 is a clinical study titled "A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease". The purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
What is the current status of trial NCT01274507?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 328 participants. The study started on 2010-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01274507?
The interventions under investigation include: Medical tests (OTHER).
Who is sponsoring clinical trial NCT01274507?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.